In a public forum held by Democratic lawmakers Richard Blumenthal and Robert Garcia, several people testified about violent ...

NFL goalposts would stand tall on the goal line for over three decades, according to the Pro Football Hall of Fame. Then, in ...

MS NOW contributor Philip Bump teared up on air Thursday as he spoke about the family of a 37-year-old Minnesota woman shot and killed by an Immigration and Customs Enforcement (ICE) officer. Her ...

With rapid improvements in AI, things are quickly moving away from AI chatbots to action-driven AI agents. AI agents are ready to change our everyday lives and how we interact with services. They ...

Discover the fascinating evolution of the Burberry logo design history, from its 1901 origins to the modern minimalist design and brand identity. It’s 1901, and a young Thomas Burberry is about to ...

More than 240 members of the notorious Mara Salvatrucha, or MS-13, gang, were sentenced to hundreds of years in prison in El Salvador. In a post on social media, the Central American country's ...

A pair of MS-13 leaders, along with two other members of the gang, were convicted Friday in Brooklyn of racketeering and the murder of four men, including two on Long Island, federal officials said. A ...

Hinton & Hinton, a men’s and women’s store in Mississippi is one of the 50 best clothing stores in America, according to a recent New York Times list. Street View ...

Five MS-13 gang members were convicted in Los Angeles on federal racketeering and murder charges after a nine-week trial. The defendants were found guilty of carrying out six brutal murders involving ...

From MS NOW and Versant to ESPN and Optimum, media and entertainment companies are shuffling letters of the alphabet to remain relevant to consumers, or Wall Street. By Alex Weprin Senior Editor The ...

SAN VICENTE, EL SALVADOR – APRIL 04: A gang member seen in a cell at the Terrorism Confinement Center (CECOT) in Tecoluca, in San Vicente, El Salvador on April 04, 2025. The Cecot prison was presented ...

Trial tests drug against relapsing form of the disease Drug candidate as effective as Roche's Ocrevus in a separate study Fenebrutinib could bring in over $1 billion in annual peak sales FRANKFURT, ...